Bayer has received Breakthrough Therapy Designation in the United States and China for sevabertinib...
NEWS
Alnylam to invest $250 million in enzymatic ligation platform to...
Alnylam Pharmaceuticals has announced a $250 million investment to expand its US manufacturing...
Lilly Phase 3 trial shows oral GLP-1 maintains weight loss after...
Eli Lilly has reported Phase 3 results showing that its investigational oral GLP-1 therapy...
Sanofi to acquire Dynavax, expanding adult vaccine portfolio
Sanofi has agreed to acquire Dynavax Technologies Corporation, adding an approved adult hepatitis B...